Potency and requirement of propofol for loss of consciousness in end-stage renal disease patients.
Not Applicable
Completed
- Conditions
- Diseases of The genitoruinary system
- Registration Number
- KCT0003734
- Lead Sponsor
- Soon Chun Hyang University Hospital Seoul
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Aged = 20, American Society of Anestheisologists physical status I-II scheduled for elective surgery.
Exclusion Criteria
1. Patients with neurological dysfuction, history of central nervous system disease, psychological disease
2. Patients on medications affecting central nervous system such as anticonvulsants, hypnotics, analgesics
3. Abnormal liver function
4. Body mass index (BMI) > 30 kg/m2
5. A history of adverse drug reaction with propofol and local anesthetics
6. A history of allergic reaxction with peanuts
7. A history of kidney transplantation
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Potency and total amount of propofol for loss of consciousness are compared between end-stage renal disease patients and normal kidney function patients.
- Secondary Outcome Measures
Name Time Method Potency and total amount of propofol for loss of consciousness are compared between cervical epidural anesthesia with monitored anesthesia care and general anesthesia among end-stage renal disease patients.